advertisement

---

Mardin CY 10

Showing records 1 to 10 | Display all abstracts from Mardin CY

82394 OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography - Reliability and Reproducibility
Hosari S
Ophthalmologica 2020; 243: 75-84

---

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Hohberger B
Frontiers in immunology 2019; 10: 2112

---

82394 OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography - Reliability and Reproducibility
Hosari S; Hohberger B
Ophthalmologica 2020; 243: 75-84

---

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Kunze R; Wallukat G
Frontiers in immunology 2019; 10: 2112

---

82394 OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography - Reliability and Reproducibility
Theelke L; Sari H
Ophthalmologica 2020; 243: 75-84

---

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Kara K
Frontiers in immunology 2019; 10: 2112

---

82394 OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography - Reliability and Reproducibility
Lucio M
Ophthalmologica 2020; 243: 75-84

---

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Mardin CY; Lämmer R
Frontiers in immunology 2019; 10: 2112

---

82394 OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography - Reliability and Reproducibility
Mardin CY
Ophthalmologica 2020; 243: 75-84

---

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Schlötzer-Schrehardt U; Hosari S; Hosari S; Horn F; Munoz L; Herrmann M
Frontiers in immunology 2019; 10: 2112

---